Eintrag weiter verarbeiten
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung ca...
Gespeichert in:
Zeitschriftentitel: | Oncogene |
---|---|
Personen und Körperschaften: | , , , , |
In: | Oncogene, 26, 2007, 18, S. 2621-2634 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
Springer Science and Business Media LLC
|
Schlagwörter: |
author_facet |
Zhong, S Fields, C R Su, N Pan, Y-X Robertson, K D Zhong, S Fields, C R Su, N Pan, Y-X Robertson, K D |
---|---|
author |
Zhong, S Fields, C R Su, N Pan, Y-X Robertson, K D |
spellingShingle |
Zhong, S Fields, C R Su, N Pan, Y-X Robertson, K D Oncogene Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer Cancer Research Genetics Molecular Biology |
author_sort |
zhong, s |
spelling |
Zhong, S Fields, C R Su, N Pan, Y-X Robertson, K D 0950-9232 1476-5594 Springer Science and Business Media LLC Cancer Research Genetics Molecular Biology http://dx.doi.org/10.1038/sj.onc.1210041 Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer Oncogene |
doi_str_mv |
10.1038/sj.onc.1210041 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Biologie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zai5vbmMuMTIxMDA0MQ |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zai5vbmMuMTIxMDA0MQ |
institution |
DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 |
imprint |
Springer Science and Business Media LLC, 2007 |
imprint_str_mv |
Springer Science and Business Media LLC, 2007 |
issn |
0950-9232 1476-5594 |
issn_str_mv |
0950-9232 1476-5594 |
language |
English |
mega_collection |
Springer Science and Business Media LLC (CrossRef) |
match_str |
zhong2007pharmacologicinhibitionofepigeneticmodificationscoupledwithgeneexpressionprofilingrevealsnoveltargetsofaberrantdnamethylationandhistonedeacetylationinlungcancer |
publishDateSort |
2007 |
publisher |
Springer Science and Business Media LLC |
recordtype |
ai |
record_format |
ai |
series |
Oncogene |
source_id |
49 |
title |
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_unstemmed |
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_full |
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_fullStr |
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_full_unstemmed |
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_short |
Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_sort |
pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant dna methylation and histone deacetylation in lung cancer |
topic |
Cancer Research Genetics Molecular Biology |
url |
http://dx.doi.org/10.1038/sj.onc.1210041 |
publishDate |
2007 |
physical |
2621-2634 |
description |
|
container_issue |
18 |
container_start_page |
2621 |
container_title |
Oncogene |
container_volume |
26 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792347801927024647 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T18:01:04.736Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Pharmacologic+inhibition+of+epigenetic+modifications%2C+coupled+with+gene+expression+profiling%2C+reveals+novel+targets+of+aberrant+DNA+methylation+and+histone+deacetylation+in+lung+cancer&rft.date=2007-04-19&genre=article&issn=1476-5594&volume=26&issue=18&spage=2621&epage=2634&pages=2621-2634&jtitle=Oncogene&atitle=Pharmacologic+inhibition+of+epigenetic+modifications%2C+coupled+with+gene+expression+profiling%2C+reveals+novel+targets+of+aberrant+DNA+methylation+and+histone+deacetylation+in+lung+cancer&aulast=Robertson&aufirst=K+D&rft_id=info%3Adoi%2F10.1038%2Fsj.onc.1210041&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792347801927024647 |
author | Zhong, S, Fields, C R, Su, N, Pan, Y-X, Robertson, K D |
author_facet | Zhong, S, Fields, C R, Su, N, Pan, Y-X, Robertson, K D, Zhong, S, Fields, C R, Su, N, Pan, Y-X, Robertson, K D |
author_sort | zhong, s |
container_issue | 18 |
container_start_page | 2621 |
container_title | Oncogene |
container_volume | 26 |
description | |
doi_str_mv | 10.1038/sj.onc.1210041 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Biologie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTAzOC9zai5vbmMuMTIxMDA0MQ |
imprint | Springer Science and Business Media LLC, 2007 |
imprint_str_mv | Springer Science and Business Media LLC, 2007 |
institution | DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4 |
issn | 0950-9232, 1476-5594 |
issn_str_mv | 0950-9232, 1476-5594 |
language | English |
last_indexed | 2024-03-01T18:01:04.736Z |
match_str | zhong2007pharmacologicinhibitionofepigeneticmodificationscoupledwithgeneexpressionprofilingrevealsnoveltargetsofaberrantdnamethylationandhistonedeacetylationinlungcancer |
mega_collection | Springer Science and Business Media LLC (CrossRef) |
physical | 2621-2634 |
publishDate | 2007 |
publishDateSort | 2007 |
publisher | Springer Science and Business Media LLC |
record_format | ai |
recordtype | ai |
series | Oncogene |
source_id | 49 |
spelling | Zhong, S Fields, C R Su, N Pan, Y-X Robertson, K D 0950-9232 1476-5594 Springer Science and Business Media LLC Cancer Research Genetics Molecular Biology http://dx.doi.org/10.1038/sj.onc.1210041 Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer Oncogene |
spellingShingle | Zhong, S, Fields, C R, Su, N, Pan, Y-X, Robertson, K D, Oncogene, Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer, Cancer Research, Genetics, Molecular Biology |
title | Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_full | Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_fullStr | Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_full_unstemmed | Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_short | Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
title_sort | pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant dna methylation and histone deacetylation in lung cancer |
title_unstemmed | Pharmacologic inhibition of epigenetic modifications, coupled with gene expression profiling, reveals novel targets of aberrant DNA methylation and histone deacetylation in lung cancer |
topic | Cancer Research, Genetics, Molecular Biology |
url | http://dx.doi.org/10.1038/sj.onc.1210041 |